<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2019-3-89-91</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-3010</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ КИШЕЧНИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BOWEL DISEASES</subject></subj-group></article-categories><title-group><article-title>Большое будущее малой молекулы</article-title><trans-title-group xml:lang="en"><trans-title>Big future for small molecule</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editorial</surname><given-names>Article</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>12</day><month>05</month><year>2019</year></pub-date><volume>0</volume><issue>3</issue><fpage>89</fpage><lpage>91</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editorial a.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/3010">https://www.med-sovet.pro/jour/article/view/3010</self-uri><abstract><p>Главная задача врача – определить верную тактику лечения. Персонализированная медицина дает возможность современному практикующему врачу максимально учитывать индивидуальные особенности пациента, предотвращая развитие осложнений и инвалидизацию. Какими терапевтическими возможностями располагают современные гастроэнтерологи в лечении язвенного колита? С этим вопросом мы обратились к председателю Российского общества по изучению воспалительных заболеваний кишечника, руководителю отделения гастроэнтерологии Московского областного научноисследовательского клинического института им. М.Ф. Владимирского, доктору медицинских наук, профессору Елене Александровне Белоусовой.</p></abstract><trans-abstract xml:lang="en"><p>The major concern for the practitioner is to determine the correct approach to the treatment. The personalized medicine allows the modern practitioner to leverage the individual patient characteristics, preventing the development of complications and disability. What therapeutic possibilities do modern gastroenterologists have for the treatment of ulcerative colitis? We asked this question to the Chairman of the Russian Society for the Study of Inflammatory Bowel Diseases, Head of the Department of Gastroenterology of Vladimirsky Moscow Regional Clinical Research Institute, Doctor of Medical Sciences, Professor Elena Alexandrovna Belousova.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
